Akari Therapeutics Plc buy krebskrebs
Start price
02.04.24
/
50%
€1.35
Target price
02.04.25
€2.20
Performance (%)
-3.70%
Price
03.05.24
€1.30
Summary
This prediction is currently active. With a performance of -3.70%, the BUY prediction by krebskrebs is trending in the wrong direction. This prediction currently runs until 02.04.25. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akari Therapeutics Plc | 26.214% | 26.214% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by krebskrebs for this prediction
In the thread Akari Therapeutics Plc diskutieren
Buy mit Kursziel 2,2